Stockscreener 앱 받기
1.57
4.27%
-0.07
전일 마감가:
$1.64
열려 있는:
$1.53
하루 거래량:
3,558
Relative Volume:
0.26
시가총액:
$69.02M
수익:
-
순이익/손실:
$-7.92M
주가수익비율:
-5.2333
EPS:
-0.3
순현금흐름:
$-7.05M
1주 성능:
-5.42%
1개월 성능:
+1.29%
6개월 성능:
-1.26%
1년 성능:
-28.64%
1일 변동 폭
$1.53
$1.72
1주일 범위
$1.53
$1.85
52주 변동 폭
$0.8001
$3.08
아네불로 파마슈티컬 Stock (ANEB) Company Profile
명칭
Anebulo Pharmaceuticals Inc
전화
737 203 5270
주소
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
ANEB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
1.68 | 72.72M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.75 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
546.17 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.11 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
573.78 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.24 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
아네불로 파마슈티컬 주식(ANEB)의 최신 뉴스
What analysts say about Anebulo Pharmaceuticals Inc. stockFast-track wealth growth - Jammu Links News
Is Anebulo Pharmaceuticals Inc. a good long term investmentFree Stock Market Knowledge Sharing - Jammu Links News
Anebulo Pharmaceuticals Inc. Stock Analysis and ForecastRapid-fire capital growth - Jammu Links News
What makes Anebulo Pharmaceuticals Inc. stock price move sharplyMarket Trend Watch - Newser
What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser
Why Anebulo Pharmaceuticals Inc. stock attracts strong analyst attentionFree Financial Group - newser.com
How GFL Environmental Inc. stock performs during market volatilityVolume Spike Monitors - Newser
How Anebulo Pharmaceuticals Inc. stock performs during market volatilityMoney Making Low Risk Plans - newser.com
Why Accretion Acquisition Corp. Equity Warrant stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
Benchmark cuts Anebulo stock target to $3, keeps Speculative Buy By Investing.com - Investing.com Canada
Anebulo Pharmaceuticals (NASDAQ:ANEB) Is In A Good Position To Deliver On Growth Plans - simplywall.st
Benchmark cuts Anebulo stock target to $3, keeps Speculative Buy - Investing.com
Anebulo Pharmaceuticals (ANEB) Price Target Lowered by Maxim Gro - GuruFocus
Anebulo Pharmaceuticals (ANEB) Sees Price Target Reduced but Ret - GuruFocus
Anebulo Pharmaceuticals Focuses on Pediatric Cannabis Toxicity Treatment - TipRanks
Anebulo Pharmaceuticals (ANEB) Projected to Post Earnings on Wednesday - Defense World
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates - Business Wire
Head to Head Contrast: OnKure Therapeutics (NASDAQ:OKUR) & Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Large Increase in Short Interest - Defense World
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - Yahoo
Anebulo Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com India
Anebulo Pharmaceuticals regains Nasdaq compliance - Investing.com Australia
Anebulo Pharmaceuticals expands shares, restructures board - Investing.com Australia
Anebulo Pharmaceuticals expands shares, restructures board By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 12.3% in March - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Mangrove Partners IM, LLC Acquires Significant Stake in Anebulo Pharmaceuticals Inc - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Anebulo Pharmaceuticals Inc Files For Resale Of Up To 15.15 Million Shares By The Selling Stockholders - Marketscreener.com
Benchmark maintains Speculative Buy on Anebulo stock, target at $8 By Investing.com - Investing.com Canada
Anebulo Pharmaceuticals enters lock-up agreement, faces Nasdaq compliance issue By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals enters lock-up agreement, faces Nasdaq compliance issue - Investing.com
Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders - MSN
Anebulo Pharmaceuticals Reports Fiscal Q2 2025 Results - TipRanks
Anebulo Pharmaceuticals Inc Files Prospectus Related To Resale Of 15.2 Million Shares Of Common Stock By Selling Stockholders- SEC Filing - Marketscreener.com
Anebulo Pharmaceuticals Inc. (ANEB) reports earnings - Quartz
Anebulo Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Anebulo Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Anebulo's Cannabis Overdose Treatment Gets FDA Priority Signal as Company Raises $15M - StockTitan
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates - Business Wire
Head to Head Contrast: ProQR Therapeutics (NASDAQ:PRQR) versus Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World
아네불로 파마슈티컬 (ANEB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.10%
자본화:
|
볼륨(24시간):